<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04597060</url>
  </required_header>
  <id_info>
    <org_study_id>Si 719/2018</org_study_id>
    <nct_id>NCT04597060</nct_id>
  </id_info>
  <brief_title>The Safety and Efficacy of Thermo-mechanical System for Fractional Ablation Associated Triamcinolone Acetonide Drug Delivery for the Treatment of Hypertrophic Scars and Keloids</brief_title>
  <official_title>The Safety and Efficacy of Thermo-mechanical System for Fractional Ablation Associated Triamcinolone Acetonide Drug Delivery for the Treatment of Hypertrophic Scars and Keloids</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to assess the safety and efficacy of Thermo-mechanical system for fractional&#xD;
      ablation associated triamcinolone acetonide drug delivery for the treatment of Hypertrophic&#xD;
      scars and Keloids.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">October 2020</start_date>
  <completion_date type="Anticipated">February 2021</completion_date>
  <primary_completion_date type="Anticipated">January 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Thickness by caliper (mm) - comparing between Thermo-mechanical system for fractional ablation associated triamcinolone acetonide drug delivery and triamcinolone acetonide injection for the treatment of Hypertrophic scars and Keloids</measure>
    <time_frame>6 months</time_frame>
    <description>cthickness by caliper in mm.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vancouver Scar Scale - comparing between Thermo-mechanical system for fractional ablation associated triamcinolone acetonide drug delivery and triamcinolone acetonide injection for the treatment of Hypertrophic scars and Keloids</measure>
    <time_frame>6 months</time_frame>
    <description>Vancouver Scar Scale between 0 to 13</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Antera Elevation Volume - comparing between Thermo-mechanical system for fractional ablation associated triamcinolone acetonide drug delivery and triamcinolone acetonide injection for the treatment of Hypertrophic scars and Keloids</measure>
    <time_frame>6 months</time_frame>
    <description>Measuring Antera Elevation Volume in mm3</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient satisfaction quartile scale - comparing between Thermo-mechanical system for fractional ablation associated triamcinolone acetonide drug delivery and triamcinolone acetonide injection for the treatment of Hypertrophic scars and Keloids</measure>
    <time_frame>6 months</time_frame>
    <description>Patient satisfaction quartile scale from 0 - 100%</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Physician evaluation quartile score - comparing between Thermo-mechanical system for fractional ablation associated triamcinolone acetonide drug delivery and triamcinolone acetonide injection for the treatment of Hypertrophic scars and Keloids</measure>
    <time_frame>6 months</time_frame>
    <description>Physician evaluation quartile score from 0-100%</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Side effect of Thermo-mechanical system, Triamcinolone itself, Injection side effect</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Side effect of Triamcinolone acetonide injection</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Keloid</condition>
  <arm_group>
    <arm_group_label>Split Keloid - first side</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Split Keloid - second side</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Thermomechanical system with corticosteroids</intervention_name>
    <description>The device in this study using Novoxel - TixelÂ®</description>
    <arm_group_label>Split Keloid - first side</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>corticosteroid injection</intervention_name>
    <description>corticosteroid injection using TA 10mg/ml</description>
    <arm_group_label>Split Keloid - second side</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy volunteers without underlying disease&#xD;
&#xD;
          -  Patient with keloid age more than 6 months and keloid thickness more than 1 mm.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Dermatitis or infection on treatment area&#xD;
&#xD;
          -  Suspected cancer on treatment area&#xD;
&#xD;
          -  Immunocompromised host&#xD;
&#xD;
          -  Pregnancy or lactating woman&#xD;
&#xD;
          -  Recieved corticosteroid injection within 2 months&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Prof. Woraphong Manuskiatti, M.D.</last_name>
    <phone>+6624197000</phone>
    <phone_ext>4333</phone_ext>
    <email>woraphong.man@mahidol.ac.th</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Chadakan Yan, M.D.</last_name>
    <phone>+66882334090</phone>
    <email>chadakanyan4090@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Dermatology, Siriraj Hospital, Mahidol University</name>
      <address>
        <city>Bangkok</city>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Woraphong Manuskiatti, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rungsima Wanitphakdeedacha, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>September 8, 2020</study_first_submitted>
  <study_first_submitted_qc>October 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 22, 2020</study_first_posted>
  <last_update_submitted>October 15, 2020</last_update_submitted>
  <last_update_submitted_qc>October 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mahidol University</investigator_affiliation>
    <investigator_full_name>Woraphong Manuskiatti, M.D.</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Keloid, thermo-mechanical system</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keloid</mesh_term>
    <mesh_term>Cicatrix, Hypertrophic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

